August 2nd, 2011
Argento's hand-held health device has been featured in the Financial Times and how it will help GB athletes ahead of the 2012 Summer Olympic Games in London.
“Argento Diagnostics – a spin-off from the UK's National Physical Laboratory – has developed a handheld device that monitors various proteins present in blood, saliva or urine that can reveal details about the condition of the body. Dr Drawer [Head of Research and Innovation for UK Sport] says such advances are 'massively important' for a coach, allowing them to change their training technique instantly. In performance terms, the new technology represents 'a big leap' forward, allowing each athlete to have a tailor-made training regime.”
Read More at the FT.com
Posted in Press | No Comments »
April 12th, 2011
Argento Diagnostics was featured in the 11 April 2011 edition of The Engineer exploring our handheld unit which could be used to create bespoke diagnostic systems for medical professionals.
One day in the not-too-distant future, medical professionals will be able to test patients for life-threatening diseases in minutes, rather than days.
That is the vision of engineers at National Physical Laboratory (NPL) spin-out Argento Diagnostics, which recently took the wraps off a customisable ’technology platform’ that could be used by its customers to build small, handheld units that could test for a range of diseases.
Read more on theengineer.co.uk
Posted in Press | No Comments »
April 7th, 2011
Argento was featured in the SET for Britain exhibition, a high profile event held annually at the House of Commons. Just being chosen to show off the research is a great achievement as each poster session is six times over-subscribed.
Paul Wilson’s poster ”Personalised testing for tailored training of elite athletes” was in the Biological and Biomedical session and was well received. There was particular interest in the research from the Physiological Society and a number of other research councils and societies.
Posted in General | No Comments »
April 6th, 2011
NPL’s diagnostic research was featured on the cover and in a two-page article in MedLab News, focusing on Argento Diagnostic’s NPL’s first spinout company. Argento’s new diagnostic tool provides instant analysis of biomakers for healthcare and sports medicine all in the palm of your hand.
View the MedLab News website. Find out more about Argento’’s Technology.
Posted in Press | No Comments »
March 30th, 2011
Argento’’s chief scientific officer Dr Robert Porter along with collegues at the National Physical Laboratory, have jointly published a new journal entitled “Silver nanoparticles and magnetic beads with electrochemical measurement as a platform for immunosensing devices”.
Download a copy from the RSC Publishing website.
The abstract from the paper is as follows;
The simplicity and analytical utility of silver nanoparticles used as immunolabels with screen-printed measurement electrodes is illustrated by demonstrating an appropriate analytical signal for myoglobin (a protein marker for muscle damage) across a range of concentrations of physiological interest for distinguishing potential myocardial infarctions from normal background levels in serum. Silver nanoparticles were used as labels on one of a pair of anti-myoglobin clones while the other clone was covalently attached to magnetic beads. The two clones were selected so as to bind to different sites on the target protein and allow the formation of complexes containing both magnetic beads and silver nanoparticles. The magnetic beads enabled protein captured from test samples to be separated from other components, while the silver nanoparticles enabled the protein to be quantified. An oxidising potential, applied to screen-printed carbon electrodes, was used to dissolve silver without the need for an external oxidising agent. Silver ions released in the process were subsequently accumulated at the measurement electrodes by applying a suitable reducing potential and, finally, analytical signals were obtained by integrating the charges passed when accumulated silver was stripped from the electrodes by applying a potential ramp. The magnitudes of the measured charges were indicative of the concentrations of myoglobin in each of the test solutions.
Posted in Journals | No Comments »
December 9th, 2010
Argento has been featured in the latest edition of New Scientist, where Argento Diagnostics CEO Keith Page discusses our nanoparticle-based scanner in relation to athletics, and how UK Sport will soon begin testing the device.
You can read the article on New Scientist‘’s site, or in their 11th December issue.
Posted in Applications, Press | No Comments »
September 24th, 2010
Keith Page, CEO of Argento Diagnostics talks about the driving force of point-of-care testing and how Argento’’s platform technology can help address those needs.
Click here to read the full story
Posted in Press | No Comments »
June 22nd, 2010
On 16th June 2010 the Financial Times featured an article on Argento in their special feature called Digital Business.
The article, “Instant mobile medical testing could save lives”, introduces Argento as an “extraordinary new technology” and, whilst brief, looks to let the general reader understand the huge breadth of opportunities available from the technology.
The article is structured around a series of questions and answers, which are summarised below:
Q. What does it do?
A. Argento revolutionises the health diagnostics industry by enabling instant blood and saliva tests, enabling quicker diagnosis (less than 10 minutes), and therefore treatment, of health issues.
Q. How does it work?
A. The device uses nanotechnology to analyse the samples of blood and saliva – read full description of Argento’s technology.
Q. Whos it for?
A. Anyone who wants fast, accurate diagnostic tests – so, paramedics, doctors, vets, sports coaches, and people with long-term illnesses. Beyond the medical industry, Argento could also help people in the aviation industry detect contamination in jet fuel, for example.
Q. Why so portable?
A. The device is roughly the size of a fat iPhone, and the silver nanoparticles it uses doesn’t use much power.
Q. Who thought it up?
A. Dr Robert Porter of the UK’s National Physical Laboratory. Argento Diagnostics is NPL’s first spin-out company.
Q. When can I have one?
A. Please contact us to place an order.
Posted in Press | No Comments »
November 19th, 2009
Argento Diagnostics and NPL win a poster award at the 1st Biosensing Technology Conference in Bristol for their poster on “Electrochemical Immunoassay for Cardiac Markers with Magnetic Particles as a Solid Phase and Silver Nanoparticles as an Electroactive Bio-Label” by Mateusz Szymanski and Robert Porter
Posted in Awards | No Comments »
November 10th, 2009
Argento Diagnostics joins the high quality shortlist for the iawards, recognising some of the most innovative British businesses.
On being shortlisted Rob Porter said, “this is great news for our company to be recognised as a business with huge potential at this early stage in our development”
The iawards in association with QinetiQ were launched by Lord Drayson and James Caan in July. They aim to celebrate the best of British science, technology and innovation. As such, all entrants had to specify the British involvement in their innovation - demonstrating that innovative thinking and development came from a British organisation or team.
The Next Big Thing category is for innovation in any area which supports our society and is yet to be fully commercialised in its widest potential. As with all categories, each entry had to illustrate how its innovative qualities relate to at least one of the following challenges:
· Addressing the healthcare needs of an ageing society;
· Increasing international security from tackling global poverty to minimising the threat of terrorism;
· Preserving finite natural resources in the face of population growth and climate change; and
· Delivering public services which make best use of new technologies.
All of the winners will be announced at the iawards gala dinner on November 16 at the Science Museum.
For more information please visit www.iawards.org.uk.
Tags: Add new tag
Posted in General, Investor Relations, Product Launch | No Comments »
